Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.42 |
| ▸ | DRD2 | P14416 | 2/20 | 0.41 |
| ▸ | DRD3 | P35462 | 2/20 | 0.41 |
| ▸ | MAOB | P27338 | 1/20 | 0.41 |
| ▸ | LTA4H | P09960 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.38 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.38 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | USP2 | O75604 | 1/20 | 0.37 |
| ▸ | HTT | P42858 | 1/20 | 0.37 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8617655 | 0.83 | POLB (0.47) | L3MBTL1DRD2KMT2AMEN1 | |
| SCHEMBL8617649 | 0.75 | AOC3 (0.48) | SMN1; SMN2ADRB2ADRB1 | |
| SCHEMBL8619834 | 0.73 | AOC3 (0.42) | ADRB2ADRB1 | |
| SCHEMBL8620885 | 0.73 | ADRB2 (0.50) | L3MBTL1TSHRADRB2ADRB1HTT | |
| SCHEMBL8622440 | 0.72 | AOC3 (0.44) | ADRB2ADRB1 | |
| SCHEMBL13408062 | 0.71 | CYP1A2 (0.42) | TSHR | |
| SCHEMBL5736618 | 0.70 | L3MBTL1 (0.49) | L3MBTL1MAOBSMN1; SMN2KMT2AMEN1 | |
| SCHEMBL6551819 | 0.70 | L3MBTL1 (0.52) | L3MBTL1MAOBKMT2AMEN1 | |
| N-Methyl Pyrrolidine (Nmp) SCHEMBL27406527 | 0.69 | KDM4E (0.36) | DRD2DRD3SMN1; SMN2KMT2AMEN1 | |
| SCHEMBL17755155 | 0.69 | SLC6A4 (0.47) | L3MBTL1TSHRKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0651735-B1 | PHARMACOLOGICALLY ACTIVE ALPHA-(TERTIARY-AMINOMETHYL)-PHENYLMETHANOL DERIVATIVES | PHARMACIA & UPJOHN AB (SE) | 1998-05-20 | — | — | EP | claimed |
| US-5527821-A | FOR TREATMENT OF URINARY INCONTINENCE | PHARMACIA AB (SE) | 1996-06-18 | — | — | US | claimed |
| EP-0651735-A1 | PHARMACOLOGICALLY ACTIVE ALPHA-(TERTIARY-AMINOMETHYL)-PHENYLMETHANOL DERIVATIVES | Pharmacia & Upjohn Aktiebolag (SE) | 1995-05-10 | — | — | EP | claimed |
| WO-1994002442-A1 | PHARMACOLOGICALLY ACTIVE α-[TERTIARY-AMINOMETHYL]-BENZENEMETHANOL DERIVATIVES | PHARMACIA AB (SE) | 1994-02-03 | — | — | WO | claimed |
| EP-0651735-B1 | PHARMACOLOGICALLY ACTIVE ALPHA-(TERTIARY-AMINOMETHYL)-PHENYLMETHANOL DERIVATIVES | PHARMACIA & UPJOHN AB (SE) | 1998-05-20 | — | — | EP | disclosed |
| US-5527821-A | FOR TREATMENT OF URINARY INCONTINENCE | PHARMACIA AB (SE) | 1996-06-18 | — | — | US | disclosed |
| EP-0651735-A1 | PHARMACOLOGICALLY ACTIVE ALPHA-(TERTIARY-AMINOMETHYL)-PHENYLMETHANOL DERIVATIVES | Pharmacia & Upjohn Aktiebolag (SE) | 1995-05-10 | — | — | EP | disclosed |
| WO-1994002442-A1 | PHARMACOLOGICALLY ACTIVE α-[TERTIARY-AMINOMETHYL]-BENZENEMETHANOL DERIVATIVES | PHARMACIA AB (SE) | 1994-02-03 | — | — | WO | disclosed |